Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OPTISON | GE Healthcare | N-020899 RX | 1997-12-31 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
albumin (human) | Biologic Licensing Application | 2010-01-07 |
albumin (human) 20% | Biologic Licensing Application | 2009-12-16 |
albumin (human) 25% | Biologic Licensing Application | 2009-12-22 |
albuminex | Biologic Licensing Application | 2024-12-31 |
alburx | Biologic Licensing Application | 2009-01-06 |
albutein | Biologic Licensing Application | 2008-07-01 |
beizray beizray | New Drug Application | 2025-09-16 |
draximage maa | Biologic Licensing Application | 2024-02-13 |
flexbumin | Biologic Licensing Application | 2007-06-15 |
human albumin grifols | Biologic Licensing Application | 2010-09-08 |
Expiration | Code | ||
---|---|---|---|
ALBUMIN HUMAN, OPTISON, GE HEALTHCARE | |||
2028-05-09 | NPP | ||
2028-05-09 | NPP | ||
2028-05-09 | NPP | ||
2028-05-09 | NPP | ||
2028-05-09 | NPP | ||
2028-05-09 | NPP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 160 | 210 | 36 | 4 | 20 | 353 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 60 | 197 | 47 | 9 | 32 | 312 |
Non-small-cell lung carcinoma | D002289 | — | — | 54 | 125 | 40 | 3 | 8 | 203 |
Neoplasms | D009369 | — | C80 | 120 | 73 | 9 | 4 | 19 | 186 |
Adenocarcinoma | D000230 | — | — | 47 | 80 | 10 | 3 | 6 | 121 |
Carcinoma | D002277 | — | C80.0 | 24 | 80 | 13 | 4 | 10 | 116 |
Triple negative breast neoplasms | D064726 | — | — | 28 | 74 | 26 | 1 | 3 | 115 |
Lung neoplasms | D008175 | — | C34.90 | 27 | 67 | 15 | 3 | 7 | 104 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 3 | 22 | 15 | 12 | 54 | 95 |
Squamous cell carcinoma | D002294 | — | — | 12 | 68 | 6 | 2 | 6 | 87 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Esophageal neoplasms | D004938 | — | C15 | 12 | 42 | 2 | — | 4 | 51 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 25 | 24 | 3 | — | 2 | 49 |
Hepatic insufficiency | D048550 | — | — | 9 | 9 | 5 | — | 23 | 40 |
Covid-19 | D000086382 | — | U07.1 | 6 | 13 | 5 | — | 15 | 37 |
Neoadjuvant therapy | D020360 | — | — | — | 23 | 4 | — | 3 | 29 |
End stage liver disease | D058625 | EFO_1001311 | K72.1 | 4 | 8 | 4 | — | 17 | 28 |
Uterine cervical neoplasms | D002583 | — | — | 4 | 17 | 3 | — | 4 | 26 |
Ovarian epithelial carcinoma | D000077216 | — | — | 10 | 12 | 1 | — | 4 | 25 |
Urinary bladder neoplasms | D001749 | — | C67 | 8 | 13 | 2 | — | 2 | 20 |
Small cell lung carcinoma | D055752 | — | — | 7 | 13 | 1 | — | 2 | 20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Wounds and injuries | D014947 | — | T14.8 | 5 | 5 | — | — | 10 | 16 |
Lymphoma | D008223 | — | C85.9 | 10 | 3 | — | — | 3 | 15 |
Sarcoma | D012509 | — | — | 8 | 10 | — | — | 2 | 15 |
Prostatic neoplasms | D011471 | — | C61 | 8 | 6 | — | — | 2 | 14 |
Left ventricular dysfunction | D018487 | — | — | 4 | 7 | — | — | 3 | 10 |
Multiple myeloma | D009101 | — | C90.0 | 3 | 3 | — | — | 4 | 9 |
Sclerosis | D012598 | — | — | 2 | 3 | — | — | 5 | 9 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 6 | 2 | — | — | 1 | 8 |
Mouth neoplasms | D009062 | EFO_0003868 | C06.9 | 1 | 5 | — | — | 2 | 8 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 4 | — | — | 3 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | — | — | 14 | 16 |
Infertility | D007246 | EFO_0000545 | — | 1 | — | — | — | 7 | 8 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | 1 | — | — | — | 7 | 8 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | — | — | — | 6 | 7 |
Hodgkin disease | D006689 | — | C81 | 5 | — | — | — | 1 | 6 |
Malaria | D008288 | EFO_0001068 | B54 | 5 | — | — | — | — | 5 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | 2 | — | — | — | 3 | 5 |
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | — | — | — | 4 | 5 |
Multiple organ failure | D009102 | EFO_1001373 | — | 1 | — | — | — | 3 | 4 |
Bariatric surgery | D050110 | — | — | 1 | — | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 8 | 8 |
Fatty liver | D005234 | EFO_0003934 | — | — | — | — | — | 8 | 8 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 7 | 7 |
Gestational diabetes | D016640 | — | O24.4 | — | — | — | — | 7 | 7 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 6 | 6 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 6 | 6 |
Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 6 | 6 |
Intestinal diseases | D007410 | — | K63.9 | — | — | — | — | 6 | 6 |
Emergence delirium | D000071257 | — | — | — | — | — | — | 5 | 5 |
Acidosis | D000138 | EFO_1000014 | E87.2 | — | — | — | — | 5 | 5 |
Drug common name | Albumin human |
INN | perflutren |
Description | Albuked (albumin human) is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 200-941-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1201451 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | CK0N3WH0SR (ChemIDplus, GSRS) |